부산대학교 도서관

Cai SF; Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Huang Y; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Lance JR; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Mao HC; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Dunbar AJ; Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; McNulty SN; Invitae, San Francisco, CA.; Druley T; Invitae, San Francisco, CA.; Li Y; Bristol Myers Squibb, New York, NY.; Baer MR; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Stock W; Department of Hematology and Oncology, University of Chicago Medical Center, Chicago, IL.; Kovacsovics T; Huntsman Cancer Institute, Salt Lake City, UT.; Blum WG; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA.; Schiller GJ; David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA.; Olin RL; Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.; Foran JM; Department of Hematology, Mayo Clinic, Jacksonville, FL.; Litzow M; Department of Hematology, Mayo Clinic, Rochester, MN.; Lin T; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas, Kansas City, KS.; Patel P; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.; Foster MC; Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Boyiadzis M; Division of Hematolog/Oncology, Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA.; Collins RH; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.; Chervin J; Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Shoben A; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Vergilio JA; Foundation Medicine, Inc, Cambridge, MA.; Heerema NA; Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Rosenberg L; Leukemia and Lymphoma Society, Rye Brook, NY.; Chen TL; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Yocum AO; Leukemia and Lymphoma Society, Rye Brook, NY.; Druggan F; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Marcus S; Leukemia and Lymphoma Society, Rye Brook, NY.; Stefanos M; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Druker BJ; Knight Cancer Institute, Portland, OR.; Mims AS; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Borate U; Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Burd A; Leukemia and Lymphoma Society, Rye Brook, NY.; Byrd JC; Department of Internal Medicine, University of Cincinnati, Cincinnati, OH.; Levine RL; Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Stein EM; Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Joshi SK; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA; email: rodland@ohsu.edu.; Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.; Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.; Piehowski P; Pacific Northwest National Laboratory, Richland, Washington, USA.; Liu T; Pacific Northwest National Laboratory, Richland, Washington, USA.; Gosline SJC; Pacific Northwest National Laboratory, Richland, Washington, USA.; McDermott JE; Pacific Northwest National Laboratory, Richland, Washington, USA.; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, USA.; Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA; email: rodland@ohsu.edu.; Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.; Traer E; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA; email: rodland@ohsu.edu.; Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.; Tyner JW; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA; email: rodland@ohsu.edu.; Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, USA.; Agarwal A; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA; email: rodland@ohsu.edu.; Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, USA.; Tognon CE; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA; email: rodland@ohsu.edu.; Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.; Rodland KD; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA; email: rodland@ohsu.edu.; Pacific Northwest National Laboratory, Richland, Washington, USA.

Publisher: Annual Reviews Country of Publication: United States NLM ID: 7607088 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-4304 (Electronic) Linking ISSN: 03621642 NLM ISO Abbreviation: Annu Rev Pharmacol Toxicol Subsets: MEDLINE

Pino JC; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, USA.; Posso C; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, USA.; Joshi SK; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, OR, USA.; Nestor M; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, USA.; Moon J; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, USA.; Hansen JR; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, USA.; Hutchinson-Bunch C; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, USA.; Gritsenko MA; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, USA.; Weitz KK; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, USA.; Watanabe-Smith K; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, USA.; Long N; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, USA.; McDermott JE; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, USA; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, USA.; Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, OR, USA; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, USA.; Liu T; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, USA.; Tyner JW; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, OR, USA; Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR, USA.; Agarwal A; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, OR, USA; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR, USA; Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR, USA.; Traer E; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, OR, USA.; Piehowski PD; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, USA.; Tognon CE; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, OR, USA.; Rodland KD; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, USA; Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR, USA. Electronic address: rodland@ohsu.edu.; Gosline SJC; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory, Richland, WA, USA. Electronic address: sara.gosline@pnnl.gov.

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Joshi SK; Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.; Pittsenbarger J; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Kennedy VE; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Peretz CAC; Division of Hematology and Oncology, Department of Pediatrics, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.; Perl AE; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Smith CC; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.; Tyner JW; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon, USA.; Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.; Traer E; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Heinrich MC; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Corless CL; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Demetri GD; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Blanke CD; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; von Mehren M; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Joensuu H; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; McGreevey LS; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Chen CJ; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Van den Abbeele AD; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Druker BJ; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Kiese B; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Eisenberg B; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Roberts PJ; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Singer S; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Fletcher CDM; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Silberman S; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Dimitrijevic S; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.; Fletcher JA; From the Oregon Health and Science University Cancer Institute, Oregon Health and Science University, and Portland Veterans Affairs Medical Center, Portland, OR; Dana-Farber Cancer Institute and Harvard Cancer Center, Boston, MA; Fox-Chase Cancer Center, Philadelphia, PA; University of Turku, Turku; University of Helsinki, Helsinki, Finland; and Novartis Oncology, Basel, Switzerland.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: PubMed not MEDLINE; MEDLINE

Zambrotta GPM; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; Hematology Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; Nicolini FE; Hématologie clinique & INSEM U1052, Centre Léon Bérard, Lyon, France.; Assouline S; Department of Medicine and Oncology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.; Busque L; Hematology Division, Research Center, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, Quebec, Canada.; Pungolino E; Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Abruzzese E; Hematology, S. Eugenio Hospital, ASL Roma2, Tor Vergata University, Rome, Italy.; Miggiano MC; Hematology Department, San Bortolo Hospital, Vicenza, Italy.; Elena C; Department of Hematology Oncology, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.; Alvarez-Larran A; Hematology Department, Hospital Clínic, Barcelona, Spain.; Triguero A; Hematology Department, Hospital Clínic, Barcelona, Spain.; Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Bucelli C; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Cerrano M; Department of Hematology, University-Hospital Città della Salute e della Scienza, Turin, Italy.; Capodanno I; Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.; Lunghi F; Department of Onco-Haematology - Haematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute and Vita-Salute Hospital, Milan, Italy.; le Coutre P; Department of Hematology, Oncology and Tumor Immunology, Charité Campus Mitte, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Galimberti S; Section of Hematology, Department of Clinical and Experimental Medicine, Azienda ospedaliera Pisana, University of Pisa, Pisa, Italy.; Caocci G; Hematology Unit, Cagliari University, Businco Hospital, Cagliari, Italy.; Maffioli M; Hematology Unit, ASST Sette Laghi, Ospedale di Circolo, Varese, Italy.; Stagno F; Division of Hematology and Bone Marrow Transplantation Unit, A.O.U. 'Policlinico-Vittorio Emanuele', University of Catania, Catania, Italy.; Saussele S; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.; Piazza R; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; Hematology Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; Druker BJ; Division of Hematology/Medical Oncology, Knight Cancer Insitute, Oregon Health & Science University, Portland, Oregon, USA.; Fava C; Department of Clinical and Biological Sciences, University of Turin, Torino, Italy.; Guglielmana V; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; Hematology Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; Colombo F; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; Hematology Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; Antolini L; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; Gambacorti-Passerini C; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; Hematology Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Eide CA; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Kurtz SE; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Division of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Kaempf A; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Long N; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Joshi SK; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Nechiporuk T; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Huang A; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Dibb CA; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Taylor A; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Bottomly D; Division of Bioinformatics and Computational Biomedicine, Department of Medical Informatics and Clinical Epidemiology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; McWeeney SK; Division of Bioinformatics and Computational Biomedicine, Department of Medical Informatics and Clinical Epidemiology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Minnier J; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Lachowiez CA; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Saultz JN; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Swords RT; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Agarwal A; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Chang BH; Division of Pediatric Hematology and Oncology, Knight Cancer Institute, Doernbecher Children's Hospital, Oregon Health and Science University, Portland, Oregon.; Druker BJ; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Division of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Tyner JW; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.; Department of Cell, Developmental, and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

Lucero OM; Department of Dermatology, Oregon Health & Science University, Portland, Oregon.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Lee JA; Clinical and Translational Science Institute, David Geffen School of Medicine, University of California, Los Angeles, California.; Bowman J; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon.; Johnson K; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon.; Sapparapu G; Clinical and Translational Science Institute, David Geffen School of Medicine, University of California, Los Angeles, California.; Thomas JK; Clinical and Translational Science Institute, David Geffen School of Medicine, University of California, Los Angeles, California.; Fan G; Department of Pathology and Clinical Laboratory Medicine, Oregon Health & Science University, Portland, Oregon.; Chang BH; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Pediatric Hematology and Oncology, Oregon Health & Science University, Portland, Oregon.; Thiel-Klare K; Division of Pediatric Hematology and Oncology, Oregon Health & Science University, Portland, Oregon.; Eide CA; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon.; Okada C; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon.; Palazzolo M; Clinical and Translational Science Institute, David Geffen School of Medicine, University of California, Los Angeles, California.; Lind E; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon.; Department of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, Oregon.; Kosaka Y; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Pediatric Hematology and Oncology, Oregon Health & Science University, Portland, Oregon.; Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon.; VB Therapeutics LLC, Jackson, Wyoming.; Lydon N; VB Therapeutics LLC, Jackson, Wyoming.; Bowers PM; Therapeutic Antibody Laboratory, Department of Pulmonology and Critical Care, David Geffen School of Medicine, Los Angeles, California.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Duong VH; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Ruppert AS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.; Mims AS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.; Borate U; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.; Stein EM; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Baer MR; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Stock W; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois, USA.; Kovacsovics T; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah, USA.; Blum W; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.; Arellano ML; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.; Schiller GJ; David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA.; Olin RL; Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California, USA.; Foran JM; Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USA.; Litzow MR; Departments of Medical Oncology, Hematology, and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Lin TL; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Patel PA; University of Texas Southwestern Medical Center Medical School, Dallas, Texas, USA.; Foster MC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.; Redner RL; Hillman Cancer Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.; Al-Mansour Z; Department of Medicine, University of Florida, Gainesville, Florida, USA.; Cogle CR; Department of Medicine, University of Florida, Gainesville, Florida, USA.; Swords RT; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Collins RH; University of Texas Southwestern Medical Center Medical School, Dallas, Texas, USA.; Vergilio JA; Foundation Medicine, Cambridge, Massachusetts, USA.; Heerema NA; Department of Pathology, College of Medicine, The Ohio State University, Columbus, Ohio, USA.; Rosenberg L; The Leukemia & Lymphoma Society, Rye Brook, New York, USA.; Yocum AO; The Leukemia & Lymphoma Society, Rye Brook, New York, USA.; Marcus S; The Leukemia & Lymphoma Society, Rye Brook, New York, USA.; Chen T; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.; Druggan F; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.; Stefanos M; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.; Gana TJ; Biopharmatech Consulting, Inc., Leesburg, Virginia, USA.; Shoben AB; Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, Ohio, USA.; Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Burd A; The Leukemia & Lymphoma Society, Rye Brook, New York, USA.; Byrd JC; Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA.; Levine RL; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Boyiadzis MM; Hillman Cancer Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Yashar WM; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.; Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon.; Curtiss BM; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.; Coleman DJ; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; VanCampen J; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.; Kong G; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.; Macaraeg J; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.; Estabrook J; Cancer Early Detection Advanced Research Center, Oregon Health & Science University, Portland, Oregon.; Demir E; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon.; Pacific Northwest National Laboratories, Richland, Washington.; Long N; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon.; Bottomly D; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon.; McWeeney SK; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon.; Tyner JW; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon.; Druker BJ; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon.; Maxson JE; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.; Braun TP; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.; Division of Oncologic Sciences, Department of Medicine, Oregon Health & Science University, Portland, Oregon.; Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE